Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03430206 · ClinicalTrials.gov registry record · NA
Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) Use in Pediatric Procedures
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 78
- Enrollment target
NCT03430206: Completed NA study, sponsored by Stanford University.
NCT03430206 is a NA study that has completed, run by Stanford University. The registered enrollment target is 78 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03430206, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 78 participants
- Enrollment target
Study Summary
THRIVE (Transnasal Humidified Rapid-Insufflation Ventilatory Exchange) refers to the use of high-flow nasal cannula to augment the ability to oxygenate and ventilate a patient under general anesthesia. The use of high-flow nasal cannula oxygen supplementation during anesthesia for surgical procedures has been a recent development in the adult population, with limited data analyzing the pediatric population. This study will determine whether high flow nasal cannula oxygen supplementation during surgical or endoscopic procedures can safely prevent desaturation events in children under anesthesia.
Interventions
- DEVICE High-flow nasal cannula
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2018-02-21 |
| Est. Completion | 2018-10-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03430206
The ClinicalTrials.gov registry entry for NCT03430206 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which High-flow nasal cannula is the first listed.
NCT03430206 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03430206 about?
NCT03430206 is a clinical study titled "Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) Use in Pediatric Procedures". THRIVE (Transnasal Humidified Rapid-Insufflation Ventilatory Exchange) refers to the use of high-flow nasal cannula to augment the ability to oxygenate and ventilate a patient under general anesthesia. The use of high-flow nasal cannula oxygen supplementation during anesthesia for surgical procedure...
What is the current status of trial NCT03430206?
This trial is currently completed. It is a NA study. The enrollment target is 78 participants. The study started on 2018-02-21. Estimated completion is 2018-10-02.
What interventions are being tested in trial NCT03430206?
The interventions under investigation include: High-flow nasal cannula (DEVICE).
Who is sponsoring clinical trial NCT03430206?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.